Related Experiment Videos
Acute kidney diseases and disorders in children with bloodstream infection: frequency, predictors, and outcomes
Misaki Akiyama1, Kentaro Nishi2, Toshihiro Matsui3
1Division of Nephrology and Rheumatology, National Center for Child Health and Development, Tokyo, Japan.
Insights
Pediatric acute kidney diseases and disorders (AKD) affect a significant number of children with bloodstream infections (BSI). Younger age is a key predictor for AKD development, highlighting the need for early intervention in pediatric kidney care.
Area of Science:
- Pediatric Nephrology
- Infectious Diseases
- Critical Care Medicine
Background:
- Acute kidney diseases and disorders (AKD) are kidney damage events lasting 7-90 days.
- Data on AKD following bloodstream infections (BSI) in children are limited.
- Understanding AKD in pediatric BSI is crucial for timely diagnosis and management.
Purpose of the Study:
- To investigate the incidence and predictors of AKD in pediatric patients with BSI.
- To compare outcomes between patients with AKD and those with acute kidney injury (AKI) without AKD.
- To identify factors associated with AKD development in this population.
Main Methods:
- Retrospective observational study of pediatric patients (<20 years) with BSI and kidney dysfunction.
- Defined AKI (0-7 days) and AKD (7-90 days) using KDIGO/ADQI criteria.
- Used logistic regression to identify predictors of AKD.
Main Results:
- 41% (41/96) of pediatric patients with BSI-related kidney dysfunction developed AKD.
- Younger age was independently associated with AKD (OR 0.91, P=0.046).
- Patients with AKD experienced higher rates of death and major adverse kidney events.
Conclusions:
- AKD is a significant complication in children with BSI, occurring even without meeting AKI criteria.
- Younger age is a risk factor for AKD in pediatric BSI.
- Further research is needed to optimize AKD management in pediatric BSI.
Background:
Pediatric acute kidney diseases and disorders (AKDs) are a new concept defined as kidney damage lasting 7-90 days from onset. Data on AKD after bloodstream infection (BSI) are limited.
Methods:
This single-center, retrospective observational study included patients aged < 20 years with BSI who were subsequently diagnosed with acute kidney injury (AKI) and/or AKD between 1 May 2013 and 31 May 2023. The index day was the date of the first positive blood culture. AKI (days 0-7) and AKD (days 7-90) were defined according to the Kidney Disease: Improving Global Outcomes/Acute Disease Quality Initiative criteria. Patients were categorized as those with AKI without AKD, AKD with AKI, and AKD without AKI. Primary comparisons included AKD (with/without AKI) versus AKI without AKD. Logistic regression analyses were conducted to identify predictors of AKD.
Results:
Among 1427 patients with positive blood cultures, 197 developed kidney dysfunction. The final cohort comprised 96 patients, including 41 patients (43%) who developed AKD. In the final cohort, 55 patients had AKI without AKD, 33 patients had AKD with AKI, and 8 patients had AKD without AKI. By multivariable logistic regression analysis, younger age (odds ratio, 0.91; 95% confidence interval, 0.84-0.99; P = 0.046) was independently associated with AKD after adjusting for intensive care unit onset, glycopeptide exposure, and white blood cell count. Compared to AKI without AKD (0/55), those with AKD (with/without AKI) had higher rates of death (6/41, 15%) and major adverse kidney events at days 30 (7/41, 17%) and 90 (8/41, 20%). All adverse outcomes occurred in the AKD with AKI subgroup.
Conclusions:
In children with bloodstream infection-associated kidney dysfunction, AKD occurred in a substantial proportion, including those not meeting the AKI criteria. Younger age was associated with AKD development.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations
Pharmacokinetics in Pediatric Patients: Drug Excretion
Chronic Kidney Disease III: Interprofessional Care